ren, Drazner, Bozkurt, & Cooper Jr., 2020; Rizk et al., 2020)
Anti-TNFα • Infliximab, adalimumab, etanercept, golimumab, certolizumab as TNFα neutralizing therapies suggested as potential agents for COVID-19 hyperinflammator